Flamel Technologies S.A. (ADR) (NASDAQ:FLML) Announces Positive Results of a First-in-Man Clinical Trial with Micropump Sodium Oxybate. Flamel Technologies S.A. (ADR) (NASDAQ:FLML) shares after opening at $12.36 moved to $13.43 on last trade day and at the end of the day closed at $13.28. Company price to sales ratio in past twelve months was calculated as 14.33 and price to cash ratio as 36.37. Flamel Technologies S.A. (ADR) (NASDAQ:FLML) showed a negative weekly performance of -0.90%.
Celsus Therapeutics PLC (NASDAQ:CLTX) major shareholder Sabby Management, Llc purchased 28,207 shares of the company’s stock on the open market in a transaction dated Wednesday, April 2nd. The stock was purchased at an average cost of $6.22 per share, for a total transaction of $175,447.54. Celsus Therapeutics PLC (ADR) (NASDAQ:CLTX) shares fell -7.92% in last trading session and ended the day on $5.70.
Bobby Kotick took a $55 million cut in compensation in 2013, the year he gained control of the video-game maker Activision Blizzard Inc. (NASDAQ:ATVI). Activision Blizzard, Inc. (NASDAQ:ATVI) shares moved down -3.43% in last trading session and was closed at $19.43, while trading in range of $19.27 – $20.08. Activision Blizzard, Inc. (NASDAQ:ATVI) year to date (YTD) performance is 10.02%.
AOL (NYSE:AOL) announced yesterday that it will renew four of its original web series for The AOL on Network, the company’s premium video platform. AOL, Inc. (NYSE:AOL) weekly performance is -7.29%. On last trading day company shares ended up $40.58. AOL, Inc. (NYSE:AOL) distance from 50-day simple moving average (SMA50) is -8.77%. Analysts mean target price for the company is $52.55.